548 related articles for article (PubMed ID: 19255330)
21. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
[TBL] [Abstract][Full Text] [Related]
22. Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas.
Lo KC; Rossi MR; Burkhardt T; Pomeroy SL; Cowell JK
Genes Chromosomes Cancer; 2007 Jan; 46(1):53-66. PubMed ID: 17044047
[TBL] [Abstract][Full Text] [Related]
23. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
Łastowska M; Viprey V; Santibanez-Koref M; Wappler I; Peters H; Cullinane C; Roberts P; Hall AG; Tweddle DA; Pearson AD; Lewis I; Burchill SA; Jackson MS
Oncogene; 2007 Nov; 26(53):7432-44. PubMed ID: 17533364
[TBL] [Abstract][Full Text] [Related]
24. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
25. Oncogene amplification in medulloblastoma: analysis of a case by comparative genomic hybridization and fluorescence in situ hybridization.
Jay V; Squire J; Bayani J; Alkhani AM; Rutka JT; Zielenska M
Pathology; 1999 Nov; 31(4):337-44. PubMed ID: 10643003
[TBL] [Abstract][Full Text] [Related]
26. C-MYC expression in medulloblastoma and its prognostic value.
Herms J; Neidt I; Lüscher B; Sommer A; Schürmann P; Schröder T; Bergmann M; Wilken B; Probst-Cousin S; Hernáiz-Driever P; Behnke J; Hanefeld F; Pietsch T; Kretzschmar HA
Int J Cancer; 2000 Sep; 89(5):395-402. PubMed ID: 11008200
[TBL] [Abstract][Full Text] [Related]
27. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.
Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D
Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376
[TBL] [Abstract][Full Text] [Related]
28. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
[TBL] [Abstract][Full Text] [Related]
29. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
30. Fast detection of MYCN copy number alterations in brain neuronal tumors by real-time PCR.
Malakho SG; Korshunov A; Stroganova AM; Poltaraus AB
J Clin Lab Anal; 2008; 22(2):123-30. PubMed ID: 18348317
[TBL] [Abstract][Full Text] [Related]
31. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.
Aldosari N; Bigner SH; Burger PC; Becker L; Kepner JL; Friedman HS; McLendon RE
Arch Pathol Lab Med; 2002 May; 126(5):540-4. PubMed ID: 11958658
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
33. Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.
Schaub R; Burger A; Bausch D; Niggli FK; Schäfer BW; Betts DR
Cancer Genet Cytogenet; 2007 Jan; 172(1):61-5. PubMed ID: 17175381
[TBL] [Abstract][Full Text] [Related]
34. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
[TBL] [Abstract][Full Text] [Related]
35. Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma.
Reardon DA; Jenkins JJ; Sublett JE; Burger PC; Kun LK
Pediatr Neurosurg; 2000 Apr; 32(4):187-91. PubMed ID: 10940769
[TBL] [Abstract][Full Text] [Related]
36. Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.
Wang M; Zhou C; Cai R; Li Y; Gong L
Diagn Pathol; 2013 Jan; 8():5. PubMed ID: 23320395
[TBL] [Abstract][Full Text] [Related]
37. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.
Chen QR; Bilke S; Wei JS; Whiteford CC; Cenacchi N; Krasnoselsky AL; Greer BT; Son CG; Westermann F; Berthold F; Schwab M; Catchpoole D; Khan J
BMC Genomics; 2004 Sep; 5():70. PubMed ID: 15380028
[TBL] [Abstract][Full Text] [Related]
38. Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation.
Nicholson J; Wickramasinghe C; Ross F; Crolla J; Ellison D
Mol Pathol; 2000 Dec; 53(6):313-9. PubMed ID: 11193050
[TBL] [Abstract][Full Text] [Related]
39. Molecular staging of intracranial ependymoma in children and adults.
Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
[TBL] [Abstract][Full Text] [Related]
40. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
Bown N; Lastowska M; Cotterill S; O'Neill S; Ellershaw C; Roberts P; Lewis I; Pearson AD;
Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]